Actieve functies van Jonathan Hahn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Tuteur SA | Directeur/Bestuurslid | 01-01-2013 | - |
| President | 01-01-2013 | - | |
| Corporate Officer/Principal | 01-01-2013 | - | |
| Tuteur SACIFIA | Directeur/Bestuurslid | 01-01-2013 | - |
| President | 01-01-2013 | - |
Loopbaan van Jonathan Hahn
Eerdere bekende functies van Jonathan Hahn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | - | - |
| KAMADA LTD. | Directeur/Bestuurslid | 25-03-2010 | - |
Opleiding van Jonathan Hahn
| University of San Andres | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistieken
Internationaal
| Argentinië | 4 |
| Verenigde Staten | 3 |
| Israël | 2 |
Operationeel
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| President | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KAMADA LTD. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Tuteur SA | |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
| Tuteur SACIFIA |
- Beurs
- Insiders
- Jonathan Hahn
- Ervaring
